Glenmark To Conduct Trials For Potential COVID-19 Drug, Shares Jump
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.
Keep The Best In Your Boundary
Keep The Best In Your Boundary
Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.